A Study of CLN-978 in Patients With Relapsed or Refractory (R/R) B Cell Non-Hodgkin Lymphoma (B-NHL)

Conditions:   NHL;   NHL, Relapsed, Adult Intervention:   Drug: CLN-978 Sponsor:   Cullinan Oncology, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials